Drug Trial Radar · NCT06928051
A Study of S-892216 in Participants With COVID-19
Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
282
Actual
Start
Jun 6, 2025
Primary completion
Sep 22, 2025
Study completion Sep 22, 2025
Sponsor
- Lead sponsor
- ShionogiIndustry
- Sponsor type
- Industry
- First posted
- Apr 15, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to investigate the antiviral effect of S-892216 in participants with coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Conditions
- COVID-19
Interventions
S-892216Drug
S-892216 will be administered orally as a tablet.
PlaceboDrug
Placebo will be administered orally as a tablet.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in SARS-CoV-2 Viral RNA Level on Day 4 as Assessed by Quantitative Reverse-transcription Polymerase Chain Reaction (qRT-PCR) of Nasopharyngeal (NP) SwabsTime frame: Baseline through Day 4
Locations
57 sites in 2 countries. Site status is shown where the registry gives one.
Healthstar Research
Hot Springs, Arkansas
Invictus Clinical Research Group LLC
Coconut Creek, Florida
Hope Clinical Trials
Coral Gables, Florida
Advanced Research for Health Improvement LLC
Immokalee, Florida
LCC Medical Research
Miami, Florida
CCM Clinical Research Group
Miami, Florida
Global Health Clinical Trials
Miami, Florida
Continental Clinical Research
Miami, Florida
Entrust Clinical Research
Miami, Florida
Kendall South Medical Center Inc
Miami, Florida
Palm Springs Community Health Center
Miami Lakes, Florida
Quality Research of South Florida
Miami Lakes, Florida
Oceane7 Medical & Research Center, Inc.
Miami Lakes, Florida
Combined Research Orlando Phase I-IV LLC
Orlando, Florida
Global Clinical Professionals
St. Petersburg, Florida
Balanced Life Health Care Solutions
Lawrenceville, Georgia
PanAmerican Clincal Research
Brownsville, Texas
Alina Clinical Trials LLC
Dallas, Texas
Care United Research, LLC
Forney, Texas
Clinical Research Partners LLC
Richmond, Virginia
Frontier Clinical Research LLC
Kingwood, West Virginia
Japanese Site 10
Multiple Locations, Japan
Japanese Site 11
Multiple Locations, Japan
Japanese Site 12
Multiple Locations, Japan
Japanese Site 13
Multiple Locations, Japan
Japanese Site 14
Multiple Locations, Japan
Japanese Site 15
Multiple Locations, Japan
Japanese Site 16
Multiple Locations, Japan
Japanese Site 17
Multiple Locations, Japan
Japanese Site 18
Multiple Locations, Japan
Japanese Site 19
Multiple Locations, Japan
Japanese Site 1
Multiple Locations, Japan
Japanese Site 20
Multiple Locations, Japan
Japanese Site 21
Multiple Locations, Japan
Japanese Site 22
Multiple Locations, Japan
Japanese Site 23
Multiple Locations, Japan
Japanese Site 24
Multiple Locations, Japan
Japanese Site 25
Multiple Locations, Japan
Japanese Site 26
Multiple Locations, Japan
Japanese Site 27
Multiple Locations, Japan
Showing 40 of 57 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.